| Blood Transfusion |
|
Addendum to guidelines on the use of irradiated blood components |
2013 |
BCSH |
|
Methylene Blue-Treated Plasma
|
2012 |
BCSH |
|
Addendum to Administration of Blood Components |
2012 |
BCSH |
|
Guidelines for pre-transfusion compatability
procedures in blood transfusion laboratories
|
2012 |
BCSH |
|
Guideline on the investigaton and management of
Acute Transfusion Reactions |
2012 |
BCSH |
|
Provision of cytomegalovirus tested blood
components position statement published |
2012 |
DoH |
|
Advisory Committee on the Safety of Blood, Tissues
and Organs (SaBTO) |
2012 |
DoH |
|
Organ Specific Management and Supportive Care in
Chronic Graft versus Host Disease |
2012 |
BCSH |
|
CG141 Acute upper GI bleeding: full guideline |
2012 |
NICE |
|
Appendices to the guidelines on validation and
qualification, including change control, for hospital transfusion
laboratories. |
2012 |
BCSH |
|
Guides on
Renal Transplantation |
2012 |
European Assoc. of Urology |
|
Validation and qualification, including change
control, for hospital transfusion laboratories |
2012 |
BCSH |
|
Change Notifications
- Guidelines for the blood transfusion services in the UK |
2011 |
UK Blood Transfusion Service |
|
CG135 Organ donation: full guideline |
2011 |
NICE |
|
CG125 Peritoneal dialysis: NICE guideline |
2011 |
NICE |
|
Blood
Transfusion and the Anaesthetist - Intra-operative Cell Salvage
|
2011 |
Association of Anaesthetists |
|
BTS Guidelines for the Prevention and Management of Cytomegalovirus
Disease after Solid Organ Transplantation |
2011 |
UK Blood Transfusion Service |
|
Guidance on the microbiological safety of human
organs, tissues and cells used in transplantation |
2011 |
DoH |
|
Post-operative Care of the Kidney Transplant
Recipient |
2011 |
Renal Association |
|
Review of the support available to individuals
infected with Hepatitis C and/or HIV by NHS supplied blood transfusions
or blood products and their dependants |
2011 |
DoH |
|
Vascular Access For Haemodialysis |
2011 |
Renal Association |
|
Assessment for transplantation (FINAL DRAFT) |
2010 |
Renal Association |
|
Blood transfusion and the anaesthetist: management
of massive haemorrhage |
2010 |
Association of Anaesthetists |
|
The irradiation of blood components |
2010 |
BCSH |
|
Long-term storage of tissue products |
2010 |
UK Blood transfusion
Service |
|
Maintaining the supply of Group O RhD negative red
cells |
2010 |
DoH |
|
Position statement: estimates of the frequency (or
risk) of HBV, HCV, HIV and HTLV I infectious donations entering the
blood supply per million donations (and 1 per million donations) tested,
UK: 2007-2009 |
2010 |
UK Blood Transfusion
Service |
|
Post-operative Care of the Kidney Transplant
Recipient |
2010 |
Renal Association |
|
Review of the Organ Donor Register by Professor
Sir Gordon Duff |
2010 |
Department of Health |
|
Validation and qualification, including change
control, for hospital transfusion laboratories
|
2010 |
BCSH |
|
Whole blood and component donor selection
guidelines |
2010 |
UK Blood Transfusion Services |
|
|
|
| General Haematology |
|
Guideline for the diagnosis and management of
myelofibrosis |
2012 |
BCSH |
|
Guidelines on the management of venous thrombosis
at unusual sites |
2012 |
BCSH |
|
Effects on routine coagulation screens and
assessment of anticoagulant intensity in patients taking oral dabigatran
or rivaroxaban |
2012 |
BCSH |
|
|
2012 |
BCSH |
|
Sickle cell acute painful episode: management of
an acute painful sickle cell episode in hospital |
2012 |
NICE |
|
Acute GvHD Diagnosis and Management |
2012 |
BCSH |
|
Chronic GvHD Diagnosis and Management |
2012 |
BCSH |
|
RA/ART clinical practice guideline on water
treatment plant and quality of water for haemodialysis |
2012 |
Renal Association |
|
SaBTO report of the Cytomegalovirus Steering Group |
2012 |
DoH |
|
Treatment of HIV-1 infected adults with
antiretroviral therapy (2012) |
2012 |
British HIV Association |
|
Hypertension
|
2011 |
NICE |
|
URGENT addendum on use of rabbit ATG for
immunosuppressive therapy |
2011 |
BCSH |
|
Guidelines on oral anticoagulation with warfarin |
2011 |
BCSH |
|
Guidelines for the laboratory investigation of
heritable disorders of platelet function |
2011 |
BCSH |
|
Management of mature T-cell and and NK-cell
neoplasms |
2011 |
BCSH |
|
Guidelines for the Management of Iron Deficiency
Anaemia |
2011 |
British Society of
Gastroenterology |
|
Routine investigation and monitoring of adult
HIV-1-infected individuals (2011) |
2011 |
British HIV Association |
|
Sickle Cell Disease in Pregnancy, Management of
(Green-top 61 |
2011 |
Royal College of
Obstetricians & Gynaecologists |
|
Self-monitoring of blood glucose in
non-insulin treated patients with type 2 diabetes: a systematic review
and meta-analysis |
2011 |
Centre for
Reviews & Dissemination |
|
Tranexamic acid is associated with less blood
transfusion in off-pump coronary artery bypass graft surgery: a
systematic review and meta-analysis |
2011 |
Centre for
Reviews & Dissemination |
|
Acute Kidney Injury |
2011 |
Renal Association |
|
Increasing the uptake of HIV testing among men who have sex with men |
2011 |
NICE |
|
Increasing the uptake of HIV testing among black Africans in England |
2011 |
NICE |
|
Endovascular repair of popliteal aneurysms |
2011 |
NICE |
|
Anaemia management in people with chronic kidney disease |
2011 |
NICE |
|
Clinical Practice Guidelines for the Detection,
Monitoring and Care of Patients with Chronic Kidney Disease (FINAL
DRAFT) |
2011 |
Renal Association |
|
The 'never events' list 2011-12 |
2011 |
DoH |
|
Anaemia |
2010 |
National Screening
Committee |
|
Anaemia in CKD (FIRST DRAFT) |
2010 |
Renal Association |
|
British HIV Association guidelines for the
management of coinfection with HIV-1 and hepatitis B or C virus 2010 |
2010 |
National library of Guidelines |
|
Cardiovascular disease in CKD (FINAL DRAFT) |
2010 |
Renal Association |
|
CKD-Mineral and Bone Disorders (CKD-MBD) |
2010 |
Renal Association |
|
Diagnosis of post-transplant lymphoproliferative
disorder in solid organ transplant recipients: BCSH and BTS Guidelines. |
2010 |
BCSH |
|
Facilities for the treatment of adults with
haematological malignancies - 'Levels of Care' |
2010 |
BCSH |
|
Guideline on the investigation and management of
adults and children presenting with thrombocytosis |
2010 |
BCSH |
|
Haemodialysis |
2010 |
Renal Association |
|
Hepatitis C - peginterferon alfa and ribavirin |
2010 |
NICE |
|
Peritoneal dialysis |
2010 |
Renal Association |
|
Prevention of transmission of blood-borne viruses
in ophthalmic surgery |
2010 |
Royal College of Ophthalmologists |
|
Sickle cell and Thalassaemia |
2010 |
National Screening Committee |
|
Sickle Cell Disease (newborn) |
2010 |
National Screening Committee |
|
Significant haemoglobinopathies: guidelines for
screening and diagnosis. |
2010 |
BCSH |
|
The UK NSC policy on Hepatitis B screening in
pregnancy |
2010 |
National Screening
Committee |
|
Vascular Access For Haemodialysis (FIRST DRAFT) |
2010 |
Renal Association |
|
|
|
|
|
Haemostasis and Thrombosis |
|
Effects on routine coagulation screens and
assessment of anticoagulant intensity in patients taking oral dabigatran
or rivaroxaban |
2012 |
BCSH |
|
Guidelines on the diagnosis
and management of Heparin induced thrombocytopenia: second edition |
2012 |
BCSH |
|
Guideline on the management of bleeding in patients on antithrombotic
agents |
2012 |
BCSH |
|
|
2012 |
SIGN |
|
|
2012 |
BCSH |
|
|
2012 |
BCSH |
|
Investigation and Management of Antiphospholipid
Syndrome |
2012 |
BCSH |
|
Guidelines on the diagnosis and management of
thrombocytopenic purpura and other thrombotic microangiopathies |
2012 |
BCSH |
|
Venous thromboembolic diseases: the management of
venous thromboembolic diseases and the role of thrombophilia testing |
2012 |
NICE |
|
Investigation
and Management of Antiphospholipid Syndrome |
2012 |
BCSH |
|
VTE |
2012 |
RCN |
|
TA245 Venous thromboembolism - apixaban (hip and
knee surgery): guidance |
2012 |
NICE |
|
Venous thromboembolism |
2011 |
NICE |
|
Clinical guidelines for testing for heritable
thrombophilia. |
2010 |
BCSH |
|
Depression,
haemochromatosis and thrombophilia screening reviews completed |
2010 |
National Screening Committee |
|
Guideline on the use of prophylactic factor VIII
concentrate in children and adults with severe haemophilia A. |
2010 |
BCSH |
|
Percutaneous occlusion of the left atrial appendage in non-valvular
atrial fibrillation for the prevention of thromboembolism |
2010 |
NICE |
|
Reducing the risk of venous thromboembolism (deep
vein thrombosis and pulmonary embolism) in patients admitted to hospital |
2010 |
NICE |
|
Thrombophilia |
2010 |
National Screening Committee |
|
Venous
thromboembolism - reducing the risk |
2010 |
NICE |
| |
|
|
| Haemato-Oncology |
|
Red cells in critical care |
2012 |
BCSH |
|
Guidelines for pre-transfusion compatability
procedures in blood transfusion laboratories |
2012 |
BCSH |
|
Guidelines for the investigation and management of
mantle cell lymphoma |
2012 |
BCSH |
|
|
2012 |
NICE |
|
Guidelines on the investigation and management of
Chronic Lymphocytic Leukaemia |
2012 |
BCSH |
|
Guidelines on obtaining consent for systemic anti-cancer therapy in
adults |
2012 |
BCSH |
|
Consultation of revised haematology measures for
the Manual of Cancer Services |
2012 |
DoH |
|
Acute GvHD Diagnosis and Management |
2012 |
BCSH |
|
Chronic GvHD Diagnosis and Management |
2012 |
BCSH |
|
TA70 Leukaemia (chronic myeloid) - imatinib:
guidance |
2012 |
NICE |
|
TA241 Leukaemia (chronic myeloid) - dasatinib,
nilotinib, imatinib (intolerant, resistant): guidance |
2012 |
NICE |
|
Revised Guidelines for the Diagnosis and Therapy
of Hairy Cell Leukaemia |
2012 |
BCSH |
|
Follicular lymphoma - rituximab (review): guidance |
2012 |
NICE |
|
The investigation and management of follicular
lymphoma |
2011 |
BCSH |
|
Lymphoma (follicular non-Hodgkin's) - rituximab |
2011 |
NICE |
|
UK Guidelines for Living Donor Kidney
Transplantation |
2011 |
BTS |
|
TA228 Multiple myeloma (first line) - bortezomib
and thalidomide: guidance |
2011 |
NICE |
|
IPG405 Cryotherapy for renal cancers: guidance |
2011 |
NICE |
|
The management of mature T-cell and and NK-cell
neoplasms |
2011 |
BCSH |
|
Leukaemia (lymphocytic) - bendamustine |
2011 |
NICE |
|
Renal
cell carcinoma (first line metastatic) - pazopanib |
2011 |
NICE |
|
Best Practice in Lymphoma Diagnosis and Reporting |
2010 |
BCSH |
|
Chronic lymphocytic leukaemia - ofatumumab |
2010 |
NICE |
|
Diagnosis of post-transplant lymphoproliferative
disorder in solid organ transplant recipients |
2010 |
BCSH/BTS |
|
Facilities for the treatment of adults with
haematological malignancies - 'Levels of Care' |
2010 |
BCSH |
|
Leukaemia (chronic lymphocytic, relapsed) - rituximab |
2010 |
NICE |
|
Lymphoma (non-Hodgkin's) - bendamustine (terminated appraisal) |
2010 |
NICE |
|
Management of post-transplant lymphoproliferative
disorder in adult solid organ transplant recipients |
2010 |
BCSH/BTS |
|
Mantle
cell lymphoma (relapsed) - temsirolimus (terminated appraisal) |
2010 |
NICE |
| |
|
|
| Service Guidance |
|
The JPAC Position Statement on
The estimated risk that a donation entering the
blood supply is a potentially infectious window period donation: risks
specific for HBV, HCV and HIV in the UK, 2010 - 2011 has been updated
|
2012 |
UK Blood
Transfusion Service |
|
The JPAC Position Statement on
Granulocyte Therapy has been updated
|
2012 |
UK Blood
Transfusion Service |
|
The JPAC Position Statement on
Creutzfeldt-Jakob Disease has been updated
|
2012 |
UK Blood
Transfusion Service |
|
|
2012 |
DoH |
|
|
2012 |
DoH |
|
JPAC Position Statement on Emerging Infections |
2012 |
UK Blood
Transfusion Service |
|
Recommendations on a change to the Donor Selection
Guidance for Pregnancy |
2012 |
UK Blood
Transfusion Service |
|
JPAC Position Statement on the estimated risk of HBV, HCV and HIV potentially infectious donations entering the UK blood supply due to the window
period of tests in use, 2008 – 2010 |
2012 |
UK Blood
Transfusion Services |
|
JPAC paper on Validation of Blood Component
Quality Following Prion Removal Procedures for Red Cell Components |
2012 |
UK Blood Transfusion Services |
|
JPAC Position Statement on Chikungunya Virus |
2012 |
UK Blood
Transfusion Services |
|
JPAC paper on Evaluation of Efficacy of Prion
Removal Filters |
2012 |
UK Blood
Transfusion Services |
|
Leukaemia (Chronic myeloid, first line) myeloid,
nilotinib... |
2012 |
NICE |
|
TA 253 Hepatititis C (genotype 1) - telaprerevir |
2012 |
NICE |
|
TA 252 Hepatititis C ( genotype 1) bocprevin |
2012 |
NICE |
|
Storage temperature
(when frozen) of fresh-frozen plasma (FFP), cryoprecipitate,
cryoprecipitate-depleted plasma and methylene blue (MB)-treated FFP and
cryoprecipitate |
2012 |
UK Blood Transfusion
Service |
|
Thawing temperature
of fresh-frozen plasma (FFP), cryoprecipitate, cryoprecipitate-depleted
plasma and methylene blue (MB)-treated FFP and cryoprecipitate
|
2012 |
UK Blood Transfusion
Service |
|
West Nile Virus (WNV)
- Whole Blood and Components Donor Selection Guidelines
|
2012 |
UK Blood Transfusion
Service |
|
West
Nile Virus (WNV) - Geographical Disease Risk Index (GDRI)
|
2012 |
UK Blood Transfusion
Service |
|
West Nile Virus (WNV)
- Living Tissue, Deceased Tissue, Bone Marrow and Peripheral Blood Stem
Cell and Cord Blood Donor Selection Guidelines
|
2012 |
UK Blood Transfusion
Service |
|
JPAC Position Statement - blood donor selection to minimise
risk of transfusion transmissible infectious agents entering the blood
supply |
2011 |
UK blood Transfusion
Service |
|
The JPAC paper on List of Evaluations has been
updated |
2011 |
UK Blood
Transfusion Services |
|
JPAC Position Statement on
CMV Seronegative vs. Leucodepleted blood
components for at risk recipients |
2011 |
UK Blood Transfusion
Services |
|
Blood donor selection to minimise risk of
transfusion transmissible infectious agents entering the blood supply |
2010 |
UK Blood Transfusion Service |
|
Granulocyte Therapy |
2010 |
UK Blood Transfusion
Therapy |
|
Guidance for coroners and donor coordinators
working with coroners |
2010 |
Department of Health |
|
JPAC Position Statement on Blood donor selection |
2010 |
UK Blood Transfusion Service |
|
JPAC Position Statement on
West Nile Virus (WNV) |
2010 |
UK Blood Transfusion Service |
|
Regulatory impact assessment: The Blood Safety and
Quality (Amendment) Regulations 2007 |
2010 |
Department of Health |
|
Test reagents and test
systems |
2010 |
UK Blood transfusion Service |